These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32558717)
1. 68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region. Dadgar H; Norouzbeigi N; Ahmadzadehfar H; Assadi M Clin Nucl Med; 2020 Aug; 45(8):e363-e364. PubMed ID: 32558717 [TBL] [Abstract][Full Text] [Related]
2. High 18F-FDG Avidity of Low-Grade Esthesioneuroblastoma. Jannin A; Turpin A; Baillet C; Aubert S; Do Cao C Clin Nucl Med; 2018 Mar; 43(3):e101-e102. PubMed ID: 29293141 [TBL] [Abstract][Full Text] [Related]
4. A case of olfactory neuroblastoma detected by (18)F-FDG PET/CT. Tanaka K; Yamamoto Y; Hoshikawa H; Nishiyama Y Clin Nucl Med; 2014 Jul; 39(7):635-6. PubMed ID: 24662664 [TBL] [Abstract][Full Text] [Related]
5. The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. Broski SM; Hunt CH; Johnson GB; Subramaniam RM; Peller PJ J Nucl Med; 2012 Aug; 53(8):1200-6. PubMed ID: 22728262 [TBL] [Abstract][Full Text] [Related]
6. Bilateral Adrenal Hyperplasia Due to Adrenocorticotropic Hormone-Secreting Esthesioneuroblastoma on FDG PET and 111In-Pentetreotide Scintigraphy. Matsusaka Y; Nakahara T; Kurihara I; Iwabuchi Y; Jinzaki M Clin Nucl Med; 2018 Jun; 43(6):452-453. PubMed ID: 29659387 [TBL] [Abstract][Full Text] [Related]
7. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Sampathirao N; Basu S J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor imaging with [ Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression. Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879 [TBL] [Abstract][Full Text] [Related]
10. Preliminary study on the evaluation of olfactory neuroblastoma using PET/CT. Wu HB; Wang QS; Zhong JM; Zhou WL; Li HS; Qiao-yu W Clin Nucl Med; 2011 Oct; 36(10):894-8. PubMed ID: 21892040 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up using 18F-FDG PET/CT for postoperative olfactory neuroblastoma. Fujioka T; Toriihara A; Kubota K; Machida Y; Nakamura S; Kishimoto S; Ohashi I; Shibuya H Nucl Med Commun; 2014 Aug; 35(8):857-63. PubMed ID: 24751700 [TBL] [Abstract][Full Text] [Related]
12. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors. Komek H; Can C; Urakçi Z; Kepenek F Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875 [TBL] [Abstract][Full Text] [Related]
14. 68Ga-DOTATOC PET/CT and MR in the Evaluation of Meningeal Metastasis From Esthesioneuroblastoma: A Case Report. Dondi F; Albano D; Bertoli M; Bertagna F; Giubbini R Clin Nucl Med; 2021 Jul; 46(7):e378-e380. PubMed ID: 33782294 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors. Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446 [TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptors imaging and therapy in a patient affected by esthesioneuroblastoma with meningeal metastases. A classic example of theranostic approach. Savelli G; Bartolomei M; Bignardi M J Neurooncol; 2016 May; 127(3):617-9. PubMed ID: 26839019 [No Abstract] [Full Text] [Related]
17. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors. Kayani I; Conry BG; Groves AM; Win T; Dickson J; Caplin M; Bomanji JB J Nucl Med; 2009 Dec; 50(12):1927-32. PubMed ID: 19910422 [TBL] [Abstract][Full Text] [Related]